ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 170 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $177,000 | -45.0% | 271,056 | -8.1% | 0.00% | – |
| Q4 2021 | $322,000 | -38.7% | 294,956 | +2.2% | 0.00% | -100.0% |
| Q3 2021 | $525,000 | -31.2% | 288,592 | -0.1% | 0.00% | 0.0% |
| Q2 2021 | $763,000 | -34.1% | 288,999 | -10.1% | 0.00% | -50.0% |
| Q1 2021 | $1,158,000 | +43.0% | 321,607 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $810,000 | 0.0% | 321,607 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $810,000 | -23.1% | 321,607 | +0.1% | 0.00% | -50.0% |
| Q2 2020 | $1,054,000 | +52.8% | 321,419 | +14.2% | 0.00% | +100.0% |
| Q1 2020 | $690,000 | -40.4% | 281,461 | +14.8% | 0.00% | -50.0% |
| Q4 2019 | $1,157,000 | +8.0% | 245,171 | -2.0% | 0.00% | 0.0% |
| Q3 2019 | $1,071,000 | -25.7% | 250,124 | +1.2% | 0.00% | -33.3% |
| Q2 2019 | $1,441,000 | +85.7% | 247,136 | +22.7% | 0.00% | +50.0% |
| Q1 2019 | $776,000 | +100.5% | 201,455 | -2.8% | 0.00% | +100.0% |
| Q4 2018 | $387,000 | -40.4% | 207,167 | +2.2% | 0.00% | 0.0% |
| Q3 2018 | $649,000 | +6.7% | 202,693 | +0.7% | 0.00% | 0.0% |
| Q2 2018 | $608,000 | -22.4% | 201,362 | +0.6% | 0.00% | -50.0% |
| Q1 2018 | $784,000 | -8.5% | 200,102 | -3.4% | 0.00% | 0.0% |
| Q4 2017 | $857,000 | -33.3% | 207,117 | -1.0% | 0.00% | -33.3% |
| Q3 2017 | $1,284,000 | -11.3% | 209,152 | -10.1% | 0.00% | 0.0% |
| Q2 2017 | $1,448,000 | -4.5% | 232,749 | -2.8% | 0.00% | 0.0% |
| Q1 2017 | $1,517,000 | +13.1% | 239,349 | -4.5% | 0.00% | 0.0% |
| Q4 2016 | $1,341,000 | -7.4% | 250,649 | -2.6% | 0.00% | 0.0% |
| Q3 2016 | $1,448,000 | +3.5% | 257,249 | +0.9% | 0.00% | 0.0% |
| Q2 2016 | $1,399,000 | -22.4% | 254,849 | +4.9% | 0.00% | -25.0% |
| Q1 2016 | $1,802,000 | +2.0% | 242,915 | +14.3% | 0.00% | 0.0% |
| Q4 2015 | $1,766,000 | -6.3% | 212,521 | +1.6% | 0.00% | -20.0% |
| Q3 2015 | $1,885,000 | -25.0% | 209,167 | -0.1% | 0.01% | -16.7% |
| Q2 2015 | $2,514,000 | +40.3% | 209,467 | +25.9% | 0.01% | +50.0% |
| Q1 2015 | $1,792,000 | +136.1% | 166,383 | +11.1% | 0.00% | +100.0% |
| Q4 2014 | $759,000 | +92.6% | 149,783 | +0.4% | 0.00% | +100.0% |
| Q3 2014 | $394,000 | -34.0% | 149,142 | +0.6% | 0.00% | -50.0% |
| Q2 2014 | $597,000 | -10.5% | 148,191 | +1.8% | 0.00% | 0.0% |
| Q1 2014 | $667,000 | +5.5% | 145,591 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $632,000 | +32.2% | 145,591 | +20.4% | 0.00% | +100.0% |
| Q3 2013 | $478,000 | +94.3% | 120,891 | +3.2% | 0.00% | 0.0% |
| Q2 2013 | $246,000 | +16.6% | 117,171 | +1.6% | 0.00% | 0.0% |
| Q1 2013 | $211,000 | – | 115,379 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
| MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
| MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
| MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
| Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
| CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
| Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
| Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
| Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |